These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9194505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.
    Kawai K, Suzuki S, Murayama Y, Watanabe Y, Yamashita K.
    Diabetes Res Clin Pract; 1992 May; 16(2):137-43. PubMed ID: 1600852
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M, Matsuda M, Sanders L, Canessa ML, DeFronzo RA.
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Giordano M, Castellino P, Solini A, Canessa ML, DeFronzo RA.
    Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692
    [Abstract] [Full Text] [Related]

  • 8. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension.
    Ghiadoni L, Huang Y, Magagna A, Buralli S, Taddei S, Salvetti A.
    J Hypertens; 2001 Mar; 19(3 Pt 2):547-51. PubMed ID: 11327628
    [Abstract] [Full Text] [Related]

  • 9. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 10. [Long-term effects of captopril versus nifedipine retard on the lipid profile of mild to moderate normolipidemic essential hypertension patients. In representation of the Eastern Andalouz Cooperative Study].
    Aranda P, López S, Aranda FJ, Carmona JR, Frutos MA, López de Novales E.
    Rev Clin Esp; 1993 Jun; 193(1):7-11. PubMed ID: 8337465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients.
    Millgård J, Hägg A, Sarabi M, Lind L.
    J Hum Hypertens; 1998 Aug; 12(8):511-6. PubMed ID: 9759984
    [Abstract] [Full Text] [Related]

  • 18. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).
    Galletti F, Strazzullo P, Capaldo B, Carretta R, Fabris F, Ferrara LA, Glorioso N, Semplicini A, Mancini M.
    J Hypertens; 1999 Mar; 17(3):439-45. PubMed ID: 10100083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.